Since CMS proposed expanding supplemental benefits for Medicare Advantage for the 2020 plan year, several industry groups have voiced their support, seeing opportunities to improve care for individuals with chronic illnesses and lower costs.
CMS has proposed expanding supplemental benefits in Medicare Advantage plans to include any benefit that “improves or maintains health,” particularly for the chronically ill population, the agency announced Jan. 30. MA plans will be able to more freely offer benefits such as meals and home modifications to better serve members with certain conditions.
Mandating pharmaceutical companies to disclose drug prices as part of Direct-to-Consumer Pharmaceutical Advertising (DTCPA) may reduce consumer interest in high-priced drugs. But the inclusion of modifiers indicating consumers will have zero out-of-pocket costs weakened the finding, according to the results of a behavioral experiment published inJAMA Internal Medicine.
The U.S. government shutdown, which is now the longest-running in history, could potentially harm consumers and undermine the stability of the Affordable Care Act healthcare insurance market, The Wall Street Journal reported.
As progressive Democrats increasingly push for universal healthcare, known as Medicare for all, support for such a plan is mixed when it comes to paying for it, according to a recent poll from the Kaiser Family Foundation.